AU7217891A - Therapeutic agents, and intermediates for the synthesis thereof - Google Patents
Therapeutic agents, and intermediates for the synthesis thereofInfo
- Publication number
- AU7217891A AU7217891A AU72178/91A AU7217891A AU7217891A AU 7217891 A AU7217891 A AU 7217891A AU 72178/91 A AU72178/91 A AU 72178/91A AU 7217891 A AU7217891 A AU 7217891A AU 7217891 A AU7217891 A AU 7217891A
- Authority
- AU
- Australia
- Prior art keywords
- intermediates
- synthesis
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9003257 | 1990-02-13 | ||
| GB909003257A GB9003257D0 (en) | 1990-02-13 | 1990-02-13 | Therapeutic agents and intermediates for the synthesis thereof |
| GB909006500A GB9006500D0 (en) | 1990-03-23 | 1990-03-23 | Therapeutic agents,and intermediates for the synthesis thereof |
| GB9006500 | 1990-03-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7217891A true AU7217891A (en) | 1991-09-03 |
Family
ID=26296657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU72178/91A Abandoned AU7217891A (en) | 1990-02-13 | 1991-02-13 | Therapeutic agents, and intermediates for the synthesis thereof |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7217891A (en) |
| WO (1) | WO1991012021A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1079805E (en) * | 1998-04-27 | 2005-03-31 | Opperbas Holding Bv | PHARMACEUTICAL COMPOSITION UNDERSTANDING FACTOR VIII AND NEUTRAL LIPOSOMES |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE151638T1 (en) * | 1987-02-20 | 1997-05-15 | Genentech Inc | METHODS AND PREPARATIONS FOR USE OF HIV ENV POLYPEPTIDES AND ANTIBODIES |
| PT88641B (en) * | 1987-10-02 | 1993-04-30 | Genentech Inc | METHOD FOR PREPARING A VARIETY OF ADHESION |
| ZA893284B (en) * | 1988-05-04 | 1990-03-28 | Igen Inc | Peptide analogs and their use as haptens to elicit catalytic antibodies |
| DK0470184T3 (en) * | 1989-04-25 | 1997-03-10 | Tanox Biosystems Inc | Specific antibodies for the CD4-binding domain in HIV |
-
1991
- 1991-02-13 AU AU72178/91A patent/AU7217891A/en not_active Abandoned
- 1991-02-13 WO PCT/GB1991/000215 patent/WO1991012021A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1991012021A2 (en) | 1991-08-22 |
| WO1991012021A3 (en) | 1991-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU656157B2 (en) | Pharmaceutical agents | |
| AU7122291A (en) | 3-arylcarbonyl-1h-indoles useful as therapeutic agents | |
| AU3888793A (en) | Novel medicament | |
| AU9089591A (en) | Inhaler | |
| AU8751391A (en) | Inhaler | |
| HU9302460D0 (en) | 5/20/4-(1,2-benzisothiazole-3-yl)-1-pierazinyl/ethyl/-6-chlorine-1,3-dihydro-2h-indole-2-one-hydrogen-chloride-mononhydrate | |
| AU2805195A (en) | Therapeutic compounds | |
| AU3284395A (en) | Synthesis of 1,1,1,3,3,-pentafluoropropane | |
| AU8043491A (en) | Fungicides | |
| AU7957791A (en) | Portable golf-sack | |
| AU8212891A (en) | Equine herpesvirus-4 tk-vaccine | |
| AU6386390A (en) | Therapeutic necleosides | |
| AU1140197A (en) | Pyridyl carbamates, process and intermediates for the preparation and use thereof | |
| AU3263493A (en) | Tonometer | |
| AU7719791A (en) | Therapeutic product | |
| AU639825B2 (en) | Substituted 1,2,4-triazinediones, processes for their preparation, intermediates therefor and their use | |
| AU2547895A (en) | Therapeutic phenoxyalkylheterocycles | |
| AU5371694A (en) | Use of the tarchonanthus camphoratus | |
| AU8043891A (en) | Fungicides | |
| EP0445827A3 (en) | 4-hydroxytetrahydropyran-2-one derivatives and intermediates for synthesizing the same | |
| AU6594690A (en) | Therapeutic agents | |
| AU2402392A (en) | New anti-diarrheic agents | |
| AU7217891A (en) | Therapeutic agents, and intermediates for the synthesis thereof | |
| AU4762993A (en) | Keratometer | |
| AU7442791A (en) | Massage arrangement |